MA34054B1 - Bromhydrate d'agomelatine hydrate et sa preparation - Google Patents
Bromhydrate d'agomelatine hydrate et sa preparationInfo
- Publication number
- MA34054B1 MA34054B1 MA35191A MA35191A MA34054B1 MA 34054 B1 MA34054 B1 MA 34054B1 MA 35191 A MA35191 A MA 35191A MA 35191 A MA35191 A MA 35191A MA 34054 B1 MA34054 B1 MA 34054B1
- Authority
- MA
- Morocco
- Prior art keywords
- preparation
- bromhydrate
- agomelatin
- hydrate
- agomelatine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Anesthesiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
L'invention porte sur un bromhydrate d'agomélatine hydraté de formule (i), dans laquelle x représente br, sur son procédé de préparation et son utilisation ainsi que sur une composition pharmaceutique le contenant. La solubilité du bromhydrate d'agomélatine hydraté obtenu par le présent procédé est considérablement supérieure à celle de l'agomélatine. Par conséquent, il est plus approprié pour la fabrication de formulations pharmaceutiques. En outre, le produit a une stabilité et une pureté supérieures. Le présent produit de haute pureté peut être obtenu par un procédé simple, plutôt qu'un procédé comprenant des étapes compliquées.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010101262639A CN102190595A (zh) | 2010-03-17 | 2010-03-17 | 阿戈美拉汀溴化氢水合物及其制备方法 |
PCT/CN2011/071912 WO2011113363A1 (fr) | 2010-03-17 | 2011-03-17 | Bromhydrate d'agomélatine hydraté et sa préparation |
Publications (1)
Publication Number | Publication Date |
---|---|
MA34054B1 true MA34054B1 (fr) | 2013-03-05 |
Family
ID=44599557
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA35191A MA34054B1 (fr) | 2010-03-17 | 2011-03-17 | Bromhydrate d'agomelatine hydrate et sa preparation |
Country Status (39)
Country | Link |
---|---|
US (1) | US8729132B2 (fr) |
EP (1) | EP2547650B1 (fr) |
JP (1) | JP5634533B2 (fr) |
KR (1) | KR101406736B1 (fr) |
CN (2) | CN102190595A (fr) |
AP (1) | AP3199A (fr) |
AU (1) | AU2011229619B2 (fr) |
BR (1) | BR112012023173B1 (fr) |
CA (1) | CA2792430C (fr) |
CL (1) | CL2012002541A1 (fr) |
CR (1) | CR20120461A (fr) |
CU (1) | CU20120136A7 (fr) |
CY (1) | CY1117134T1 (fr) |
DK (1) | DK2547650T3 (fr) |
EA (1) | EA022066B1 (fr) |
EC (1) | ECSP12012156A (fr) |
ES (1) | ES2572427T3 (fr) |
GE (1) | GEP20156232B (fr) |
GT (1) | GT201200260A (fr) |
HK (1) | HK1177732A1 (fr) |
HN (1) | HN2012001923A (fr) |
HR (1) | HRP20151343T1 (fr) |
HU (1) | HUE026673T2 (fr) |
IL (1) | IL221783A (fr) |
MA (1) | MA34054B1 (fr) |
ME (1) | ME02309B (fr) |
MX (1) | MX2012010594A (fr) |
MY (1) | MY160337A (fr) |
NI (1) | NI201200141A (fr) |
NZ (1) | NZ602451A (fr) |
PE (1) | PE20130014A1 (fr) |
PL (1) | PL2547650T3 (fr) |
PT (1) | PT2547650E (fr) |
RS (1) | RS54449B1 (fr) |
SG (1) | SG183869A1 (fr) |
SI (1) | SI2547650T1 (fr) |
TN (1) | TN2012000436A1 (fr) |
UA (1) | UA105424C2 (fr) |
WO (1) | WO2011113363A1 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2978916B1 (fr) | 2011-08-10 | 2013-07-26 | Servier Lab | Composition pharmaceutique solide pour administration buccale d'agomelatine |
US9409857B2 (en) * | 2012-05-14 | 2016-08-09 | Shanghai Righthand Pharmtech, Co., Ltd. | Agomelatine sulfuric acid complex, and preparation method and application thereof |
CN102718675B (zh) * | 2012-06-07 | 2015-03-25 | 上海右手医药科技开发有限公司 | 阿戈美拉汀甲磺酸复合物及其制备方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2658818B1 (fr) * | 1990-02-27 | 1993-12-31 | Adir Cie | Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
DE01991193T1 (de) * | 2000-10-30 | 2004-07-08 | Teva Pharmaceutical Industries Ltd. | Neue kristall- und solvatformen von ondansetronhydrochlorid und verfahren zu deren herstellung |
FR2890562B1 (fr) * | 2005-09-09 | 2012-10-12 | Servier Lab | Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement des troubles du sommeil chez le patient deprime |
FR2899472B1 (fr) * | 2006-04-07 | 2008-09-12 | Servier Lab | Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement du trouble anxiete generalisee |
CN101481321B (zh) * | 2009-02-27 | 2012-04-18 | 上海医药工业研究院 | 阿戈美拉汀卤化氢复合物及其制备方法 |
CN101585779B (zh) * | 2009-03-10 | 2014-04-02 | 上海医药工业研究院 | 阿戈美拉汀的晶型vi及其制备方法和应用 |
-
2010
- 2010-03-17 CN CN2010101262639A patent/CN102190595A/zh active Pending
-
2011
- 2011-03-17 DK DK11755680.3T patent/DK2547650T3/en active
- 2011-03-17 NZ NZ602451A patent/NZ602451A/en not_active IP Right Cessation
- 2011-03-17 ES ES11755680T patent/ES2572427T3/es active Active
- 2011-03-17 JP JP2012557393A patent/JP5634533B2/ja active Active
- 2011-03-17 GE GEAP201112870A patent/GEP20156232B/en unknown
- 2011-03-17 BR BR112012023173-1A patent/BR112012023173B1/pt not_active IP Right Cessation
- 2011-03-17 SG SG2012065017A patent/SG183869A1/en unknown
- 2011-03-17 PT PT117556803T patent/PT2547650E/pt unknown
- 2011-03-17 PE PE2012001449A patent/PE20130014A1/es active IP Right Grant
- 2011-03-17 SI SI201130723T patent/SI2547650T1/sl unknown
- 2011-03-17 AP AP2012006493A patent/AP3199A/xx active
- 2011-03-17 ME MEP-2016-9A patent/ME02309B/me unknown
- 2011-03-17 CA CA2792430A patent/CA2792430C/fr active Active
- 2011-03-17 RS RS20150831A patent/RS54449B1/en unknown
- 2011-03-17 US US13/635,087 patent/US8729132B2/en active Active
- 2011-03-17 WO PCT/CN2011/071912 patent/WO2011113363A1/fr active Application Filing
- 2011-03-17 EP EP11755680.3A patent/EP2547650B1/fr active Active
- 2011-03-17 HU HUE11755680A patent/HUE026673T2/en unknown
- 2011-03-17 MA MA35191A patent/MA34054B1/fr unknown
- 2011-03-17 AU AU2011229619A patent/AU2011229619B2/en not_active Ceased
- 2011-03-17 MY MYPI2012700614A patent/MY160337A/en unknown
- 2011-03-17 KR KR1020127026897A patent/KR101406736B1/ko active IP Right Grant
- 2011-03-17 CN CN201180024413.8A patent/CN102892749B/zh not_active Expired - Fee Related
- 2011-03-17 MX MX2012010594A patent/MX2012010594A/es active IP Right Grant
- 2011-03-17 UA UAA201211719A patent/UA105424C2/uk unknown
- 2011-03-17 EA EA201201293A patent/EA022066B1/ru unknown
- 2011-03-17 PL PL11755680T patent/PL2547650T3/pl unknown
-
2012
- 2012-08-31 TN TNP2012000436A patent/TN2012000436A1/en unknown
- 2012-09-04 IL IL221783A patent/IL221783A/en not_active IP Right Cessation
- 2012-09-11 CR CR20120461A patent/CR20120461A/es unknown
- 2012-09-12 NI NI201200141A patent/NI201200141A/es unknown
- 2012-09-13 CL CL2012002541A patent/CL2012002541A1/es unknown
- 2012-09-14 HN HN2012001923A patent/HN2012001923A/es unknown
- 2012-09-14 EC ECSP12012156 patent/ECSP12012156A/es unknown
- 2012-09-17 GT GT201200260A patent/GT201200260A/es unknown
- 2012-09-17 CU CU2012000136A patent/CU20120136A7/es unknown
-
2013
- 2013-04-23 HK HK13104895.3A patent/HK1177732A1/xx not_active IP Right Cessation
-
2015
- 2015-12-08 HR HRP20151343TT patent/HRP20151343T1/hr unknown
-
2016
- 2016-01-18 CY CY20161100041T patent/CY1117134T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA33224B1 (fr) | Derives de proline comme inhibiteurs de la cathepsine | |
EA201201294A1 (ru) | Гидрат гидрохлорида агомелатина и его получение | |
MY160460A (en) | Agomelatine hydrochloride hydrate and preparation thereof | |
JOP20190072A1 (ar) | مشتقات 1، 3 سيكلوبوتان ثنائي الاستبدال أو آزيتيدين كمثبطات للإنزيم المخلق للبروستاجلاندين d المكون للدم | |
CN105263582A (zh) | 包含油体、脂肪酸、氨基酸表面活性剂和n-甲基-n-酰基葡糖胺的组合物 | |
CN1960644A (zh) | 生理学冷却组合物 | |
FR2926554B1 (fr) | Derives de carboxamides azabicycliques, leur preparation et leur application en therapeutique | |
MA30694B1 (fr) | Derives de n-(amino-heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique. | |
MA37888A1 (fr) | Composition pharmaceutique enrobée contenant du régorafenib | |
EA201170289A1 (ru) | Фармацевтические композиции и способы их получения при низкой концентрации примесей | |
MA34054B1 (fr) | Bromhydrate d'agomelatine hydrate et sa preparation | |
MA45782B1 (fr) | Modulateurs du récepteur de cxcr7 pipéridine | |
MA34313B1 (fr) | Formulation pharmaceutique sous la forme de comprimés bicouches comprenant un inhibiteur de hmg-coa réductase et d'irbésartan | |
MA35158B1 (fr) | Formulations topiques de type suspension comprenant un depsipeptide cyclique | |
EA201990688A1 (ru) | Полиморфные формы соединения, представляющего собой ингибитор киназ, содержащая их фармацевтическая композиция, способ их получения и их применение | |
MA38410A1 (fr) | Composés d'azétidinyloxyphénylpyrrolidine | |
MA38679B1 (fr) | Modulateurs du récepteur de cxcr7 | |
JP2017200909A (ja) | ロキソプロフェン配合皮膚用外用剤 | |
MA37524B1 (fr) | Procedes de production de chlorhydrate d'anamoreline presentant une teneur en chlorure regulee | |
MA29852B1 (fr) | Synthese d'inhibiteurs de la renine impliquant une reaction de cycloaddition | |
HK1167388A1 (en) | Anticancer compound and pharmaceutical composition containing the same | |
MX2014001065A (es) | Formulaciones de (trimetoxifenilamino) pirimidilino nuevas. | |
RS51962B (en) | NEW PROCEDURE FOR THE SYNTHESIS OF IVABRADINE AND ITS ADDITIONAL SALTS WITH PHARMACEUTICALLY ACCEPTABLE ACID | |
CA2674770A1 (fr) | Nouveau procede d'obtention de la forme cristalline v de l'agomelatine | |
CN1293864C (zh) | 含有用磺异苯酮稳定的酮洛芬的局部用制剂 |